a publication, as held by issuu.com, noted the scoping study was due in May. Has the scoping study been delayed for release to be tucked inside discreetly for its status in the DFS? Isn’t that problematic delaying release of the status of a study?
- Forums
- ASX - By Stock
- FFX
- our globally significant Lithium Resource
our globally significant Lithium Resource, page-113
-
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online